Source-grounded facts extracted from MEDICAL PROPERTIES TRUST INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
MEDICAL PROPERTIES TRUST INC shareholders approved Approval of Medical Properties Trust, Inc. Second Amended and Restated 2019 Equity Incentive Plan at the 2026-05-28 meeting.
“Proposal 4: The approval of the Medical Properties Trust, Inc. Second Amended and Restated 2019 Equity Incentive Plan: For: Against: Abstensions: Broker Non-Votes: 280,147,111 60,763,845 5,385,218 122,390,383”
MEDICAL PROPERTIES TRUST INC shareholders approved Advisory vote on named executive officer compensation at the 2026-05-28 meeting.
“Proposal 3: The approval of a non-binding, advisory vote on named executive officer compensation: For: Against: Abstensions: Broker Non-Votes: 245,721,749 96,721,390 3,853,035 122,390,383”
MEDICAL PROPERTIES TRUST INC shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-28 meeting.
“Proposal 2: The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026: For: Against: Abstensions: Broker Non-Votes: 459,883,831 6,189,396 2,613,330 —”
MEDICAL PROPERTIES TRUST INC shareholders approved Election of nine directors at the 2026-05-28 meeting.
“Proposal 1: The election of nine directors to the board of directors of the Company, to serve until the next annual meeting of stockholders in 2027 or until their respective successors are elected and qualify: Nominee: For: Against: Abstensions: Broker Non-Votes: Edward K. Aldag, Jr. 326,606,762 14,394,945 5,294,467 122,390,383 G. Steven Dawson 327,763,006 14,290,105 4,243,063 122,390,383 R. Steven Hamner 323,486,576 18,502,877 4,306,721 122,390,383 Caterina A. Mozingo 329,917,176 12,147,873 4,231,125 122,390,383 Emily W. Murphy 324,431,895 17,629,502 4,234,777 122,390,383 Elizabeth N. Pitman 320,148,318 21,945,226 4,202,630 122,390,383 D. Paul Sparks, Jr. 313,040,588 28,974,759 4,280,827 122,390,383 Michael G. Stewart 326,486,132 15,528,913 4,281,129 122,390,383 C. Reynolds Thompson, III 319,263,889 22,700,542 4,331,743 122,390,383”
MEDICAL PROPERTIES TRUST INC reported first quarter ended March 31, 2026 results: net income Net income of $0.05.
“Net income of $0.05 and Normalized Funds from Operations (“NFFO”) of $0.14 for the 2026 first quarter, all on a per share basis;”
MEDICAL PROPERTIES TRUST INC incurred senior notes of $1,500,000,000 aggregate principal amount (Dollar Notes) and €1,000,000,000 aggregate principal amount (Euro Notes) at 8.500% (Dollar Notes) and 7.000% (Euro Notes) maturing February 15, 2032.
“and €1,000,000,000 aggregate principal amount of the Issuers’ 7.000% Senior Secured Notes due 2032”
MEDICAL PROPERTIES TRUST INC received a nyse noncompliance notice notice regarding late filing (rules 802.01E).
“May 16, 2024, the Company received a notice (the “Notice”) from the New York Stock Exchange (“NYSE”) indicating that, due to the delay in filing of the Quarterly Report, the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual, which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Notice has no immediate effect on the listing of the Company’s common stock on the NYSE. Under NYSE rules, the Company has six months from May 15, 2024 to regain compliance with NYSE listing standards by filing the Quarte”
MEDICAL PROPERTIES TRUST INC announced a impairment with charges of approximately $470 million of additional impairment charges affecting investments in Steward, including 9.9% equity interest and $362 million loan due from affiliates of Steward.
“the Company has concluded the investments in Steward have been further materially impaired and has recorded approximately $470 million of additional impairment charges in the quarter ended March 31, 2024 that fully reserves for the remaining value of our 9.9% equity interest in Steward and the $362 million loan due from affiliates of Steward, along with an accrual for property taxes and obligations not paid by Steward under its master leases.”
MEDICAL PROPERTIES TRUST INC reported first quarter ended March 31, 2024 results: net income ($736 million) (($1.23) per share), EPS ($1.23) per share.
“Net loss for the first quarter ended March 31, 2024 was ($736 million) (($1.23) per share) compared to net income of $33 million ($0.05 per share) in the year earlier period.”
MEDICAL PROPERTIES TRUST INC completed a disposition involving Blue Owl RE Nucleus Holdco LLC for 886 million (closed 2024-04-12).
“approximate 25% interest in the Venture with an aggregate agreed valuation of approximately $1.2 billion, and the Fund purchased an approximate 75% interest in the Venture for $886 million. There are no material relationships, other than in respect of the Venture, between the Company, the Operating Partnership, and the Fund or any of their affiliates. Simultaneous”
MEDICAL PROPERTIES TRUST INC entered into a asset purchase with a newly formed joint venture valued at approximately $1.1 billion (effective 2024-04-12).
“Also on April 12, 2024, the Company sold its interest in five Utah hospitals to a newly formed joint venture, generating immediate cash proceeds of approximately $1.1 billion”
MEDICAL PROPERTIES TRUST INC amended Australia Facility Amendment with Evolution Trustees Limited, as trustee for MPT Australia Realty Trust, Bank of America, N.A., as administrative agent, and the lenders party thereto (effective 2024-04-12).
“and (ii) the Fifth Amendment (the “Australia Facility Amendment”) to the Syndicated Facility Agreement, dated as of May 23, 2019, by and among the Company, the Borrower, Evolution Trustees Limited, as trustee for MPT Australia Realty Trust, Bank of America, N.A. as administrative agent and the lenders party thereto (the “Australia Facility”).”
MEDICAL PROPERTIES TRUST INC amended Credit Facility Amendment with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto (effective 2024-04-12).
“On April 12, 2024, Medical Properties Trust, Inc., a Maryland corporation (the “Company”), and MPT Operating Partnership, L.P., a Delaware limited partnership and the Company’s operating partnership (the “Operating Partnership” or the “Borrower”), entered into (i) Amendment No. 1 (the “Credit Facility Amendment”) to the Second Amended and Restated Revolving Credit and Term Loan Agreement, dated as of June 29, 2022, by and among the Company, the Borrower, JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto (the “Credit Facility”),”
MEDICAL PROPERTIES TRUST INC reported the fiscal year ended December 31, 2023 results: EPS ($0.93) per share.
“net loss of ($0.93) and NFFO of $1.59 for the full-year 2023”
MEDICAL PROPERTIES TRUST INC reported the fourth quarter ended December 31, 2023 results: EPS ($1.11) per share.
“Net loss of ($1.11) and Normalized Funds from Operations ("NFFO") of $0.36 for the 2023 fourth quarter”
MEDICAL PROPERTIES TRUST INC reported the third quarter ended September 30, 2023 results: net income $0.19, EPS $0.19 per diluted share.
“Medical Properties Trust, Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2023.”
MEDICAL PROPERTIES TRUST INC shareholders voted on The recommendation of a non-binding, advisory resolution on the frequency of future advisory votes on executive compensation at the 2023-05-25 meeting.
“Proposal 4: The recommendation of a non-binding, advisory resolution on the frequency of future advisory votes on executive compensation: 1 Year: 2 Years: 3 Years: Abstentions: Broker Non-Votes: 295,047,986 1,753,210 11,308,651 2,225,365 143,662,598”
MEDICAL PROPERTIES TRUST INC shareholders approved The approval of a non-binding, advisory resolution approving named executive officer compensation at the 2023-05-25 meeting.
“Proposal 3: The approval of a non-binding, advisory resolution approving named executive officer compensation: For: Against: Abstentions: Broker Non-Votes: 238,275,985 67,708,882 4,350,345 143,662,598”
MEDICAL PROPERTIES TRUST INC shareholders approved The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023 at the 2023-05-25 meeting.
“Proposal 2: The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023: For: Against: Abstentions: Broker Non-Votes: 444,042,338 7,944,062 2,011,410 —”
MEDICAL PROPERTIES TRUST INC shareholders approved Election of nine directors to the board of directors of the Company, to serve until the next annual meeting of stockholders in 2024 or until their respective successors are elected and qualify at the 2023-05-25 meeting.
“Proposal 1: The election of nine directors to the board of directors of the Company, to serve until the next annual meeting of stockholders in 2024 or until their respective successors are elected and qualify: Nominee: For: Against: Abstentions: Broker Non-Votes: Edward K. Aldag, Jr. 291,239,235 16,475,354 2,620,623 143,662,598 G. Steven Dawson 284,577,727 23,717,204 2,040,281 143,662,598 R. Steven Hamner 286,819,741 21,775,405 1,740,066 143,662,598 Caterina A. Mozingo 302,693,171 5,800,161 1,841,880 143,662,598 Emily W. Murphy 299,825,641 8,638,234 1,871,337 143,662,598 Elizabeth N. Pitman 295,397,644 12,960,903 1,976,665 143,662,598 D. Paul Sparks, Jr. 298,958,358 9,450,398 1,926,456 143,662,598 Michael G. Stewart 293,526,754 14,880,911 1,927,547 143,662,598 C. Reynolds Thompson, III 296,395,393 12,064,891 1,874,928 143,662,598”
MEDICAL PROPERTIES TRUST INC reported the first quarter ended March 31, 2023 results: revenue approximately $19.7 billion, net income $33 million ($0.05 per diluted share), EPS $0.05. Guidance reaffirmed.
“facilitate MPT’s conversion of certain existing and future real estate obligations of Prospect into additional managed care equity. The Company has total assets of approximately $19.7 billion, including $13.7 billion of general acute care hospitals, $2.5 billion of behavioral health facilities and $1.7 billion of post-acute facilities. MPT’s portfolio includes 444”
MEDICAL PROPERTIES TRUST INC reported the full-year ended December 31, 2022 results: net income $903 million, EPS $1.50 per diluted share. Guidance initiated.
“Operating results for the fourth quarter and year ended December 31, 2022 were a net loss of ($140) million (($0.24) per diluted share) and net income of $903 million ($1.50 per diluted share), respectively, compared to net income of $207 million ($0.34 per diluted share) and $656 million ($1.11 per diluted share) in the year earlier periods.”
MEDICAL PROPERTIES TRUST INC reported the fourth quarter ended December 31, 2022 results: net income ($140) million, EPS ($0.24) per diluted share. Guidance initiated.
“Operating results for the fourth quarter and year ended December 31, 2022 were a net loss of ($140) million (($0.24) per diluted share) and net income of $903 million ($1.50 per diluted share), respectively, compared to net income of $207 million ($0.34 per diluted share) and $656 million ($1.11 per diluted share) in the year earlier periods.”
Emmett E. McLean departed as Executive Vice President, Chief Operating Officer, and Secretary at MEDICAL PROPERTIES TRUST INC.
“On February 16, 2023, Emmett E. McLean notified the Board of Directors (the “Board”) of Medical Properties Trust, Inc. (the “Company”) of his intent to retire as Executive Vice President, Chief Operating Officer, and Secretary of the Company, effective September 1, 2023.”
MEDICAL PROPERTIES TRUST INC reported three and nine months ended September 30, 2022 results: net income Net income for the 2022 third quarter ended September 30, 2022 was $222 million ($0.37 per diluted share), EPS Net income for the 2022 third quarter ended September 30, 2022 was $222 million ($0.37 per diluted share). Guidance raised.
“On October 27, 2022, Medical Properties Trust, Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2022.”
Emily W. Murphy was appointed as Director at MEDICAL PROPERTIES TRUST INC.
“On February 17, 2022, the board of directors (the “Board”) of Medical Properties Trust, Inc. (the “Company”), upon unanimous recommendation of the Ethics, Nominating and Corporate Governance Committee of the Board, appointed Emily W. Murphy as a member of the Board effective as of the same day.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.